Cargando…

Catalase Protects Biofilm of Staphylococcus aureus against Daptomycin Activity

Daptomycin is recommended for the treatment of Staphylococcus aureus infections due to its bactericidal activity. However, its mechanism of action is poorly understood. The involvement of reactive oxygen species (ROS) in the bactericidal activity of daptomycin has been proved against planktonic S. a...

Descripción completa

Detalles Bibliográficos
Autores principales:	El Haj, Cristina, Lichtenberg, Mads, Nielsen, Karen Leth, Bjarnsholt, Thomas, Jensen, Peter Østrup
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146090/ https://www.ncbi.nlm.nih.gov/pubmed/33946290 http://dx.doi.org/10.3390/antibiotics10050511

Ejemplares similares

Staphylococcus aureus Augments Release of Matrix Metalloproteinase-8 from Human Polymorphonuclear Leukocytes
por: KIRKETERP-MØLLER, Klaus, et al.
Publicado: (2020)

Elasnin Effectively Eradicates Daptomycin-Resistant Methicillin-Resistant Staphylococcus aureus Biofilms
por: Sulaiman, Jordy Evan, et al.
Publicado: (2022)

Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin
por: Jiang, Jhih-Hang, et al.
Publicado: (2015)

Combined Staining Techniques for Demonstration of Staphylococcus aureus Biofilm in Routine Histopathology
por: Jensen, Louise Kruse, et al.
Publicado: (2018)

Role of Daptomycin in the Induction and Persistence of the Viable but Non-Culturable State of Staphylococcus Aureus Biofilms
por: Pasquaroli, Sonia, et al.
Publicado: (2014)

New Attempts to Inhibit Methicillin-Resistant Staphylococcus aureus Biofilm? A Combination of Daptomycin and Azithromycin
por: Zhou, Ye, et al.
Publicado: (2023)

The structure–function relationship of Pseudomonas aeruginosa in infections and its influence on the microenvironment
por: Lichtenberg, Mads, et al.
Publicado: (2022)

The Combination of Low-Frequency Ultrasound and Antibiotics Improves the Killing of In Vitro Staphylococcus aureus and Pseudomonas aeruginosa Biofilms
por: Kvich, Lasse, et al.
Publicado: (2022)

Daptomycin in treatment of Methicillin-resistant Staphylococcus aureus diskitis
por: Parlato, Ciro, et al.
Publicado: (2011)

Antibiotic Combinations with Daptomycin for Treatment of Staphylococcus aureus Infections
por: Nadrah, Kristina, et al.
Publicado: (2011)

Daptomycin susceptibility of methicillin resistant Staphylococcus aureus (MRSA)
por: Kaur, Rajneet, et al.
Publicado: (2012)

117. Adjunctive Daptomycin in the Treatment of staphylococcus Aureus Bacteremia
por: Cheng, Matthew P, et al.
Publicado: (2020)

Fitness Cost of Daptomycin-Resistant Staphylococcus aureus Obtained from in Vitro Daptomycin Selection Pressure
por: Li, Shuguang, et al.
Publicado: (2017)

Prevalence of biofilms in acute infections challenges a longstanding paradigm
por: Kolpen, Mette, et al.
Publicado: (2022)

Do Mixed-Species Biofilms Dominate in Chronic Infections?–Need for in situ Visualization of Bacterial Organization
por: Kvich, Lasse, et al.
Publicado: (2020)

1507. Pharmacodynamic Target Attainment of Daptomycin Against Staphylococcus aureus for Treatment of Pediatric Osteomyelitis
por: Stimes, Grant, et al.
Publicado: (2019)

Daptomycin approved in Japan for the treatment of methicillin-resistant Staphylococcus aureus
por: Hagihara, Mao, et al.
Publicado: (2012)

Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus
por: Ma, Zhuo, et al.
Publicado: (2018)

What’s in a name? Characteristics of clinical biofilms
por: Lichtenberg, Mads, et al.
Publicado: (2023)

Genomic and Long-Term Transcriptomic Imprints Related to the Daptomycin Mechanism of Action Occurring in Daptomycin- and Methicillin-Resistant Staphylococcus aureus Under Daptomycin Exposure
por: Cafiso, Viviana, et al.
Publicado: (2020)

1539. Dalbavancin, Vancomycin, and Daptomycin Alone and in Combination with Cefazolin Against Vancomycin Intermediate-Resistant (VISA) and Daptomycin Non-Susceptible (DNS) Staphylococcus aureus
por: Abdul-Mutakabbir, Jacinda, et al.
Publicado: (2019)

Evaluation of Daptomycin Non-Susceptible Staphylococcus aureus for Stability, Population Profiles, mprF Mutations, and Daptomycin Activity
por: Steed, Molly E., et al.
Publicado: (2013)

In Vitro Activity of Rifampicin Combined with Daptomycin or Tigecycline on Staphylococcus haemolyticus Biofilms
por: Szczuka, Ewa, et al.
Publicado: (2015)

Biofilm Survival Strategies in Chronic Wounds
por: Thaarup, Ida Clement, et al.
Publicado: (2022)

Glucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus Persisters
por: Prax, Marcel, et al.
Publicado: (2016)

The Role of Subinhibitory Concentrations of Daptomycin and Tigecycline in Modulating Virulence in Staphylococcus aureus
por: Atshan, Salman Sahab, et al.
Publicado: (2021)

Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm Matrix
por: Kong, Eric F., et al.
Publicado: (2016)

High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: Case report
por: Chen, Liang-Yu, et al.
Publicado: (2011)

596. Distinct, Segregated Daptomycin-Susceptible and Daptomycin-Nonsusceptible Staphylococcus aureus Populations Associated with Tricuspid-Valve Infective Endocarditis
por: Miller, Christopher R, et al.
Publicado: (2019)

Inoculum Concentration Influences Pseudomonas aeruginosa Phenotype and Biofilm Architecture
por: Lichtenberg, Mads, et al.
Publicado: (2022)

Actions of N-acetylcysteine, daptomycin, vancomycin, and linezolid on methicillin-resistant Staphylococcus aureus biofilms in the ventriculoperitoneal shunt infections: an experimental study
por: Kuruoglu, Tuba, et al.
Publicado: (2022)

1588. Delafloxacin Activity Against Staphylococcus aureus with Reduced Susceptibility or Resistance to Methicillin, Vancomycin, Daptomycin, or Linezolid
por: Saravolatz, Louis D, et al.
Publicado: (2019)

Adaptation of Pseudomonas aeruginosa biofilms to tobramycin and the quorum sensing inhibitor C-30 during experimental evolution requires multiple genotypic and phenotypic changes
por: Bové, Mona, et al.
Publicado: (2023)

The clinical impact of bacterial biofilms
por: Høiby, Niels, et al.
Publicado: (2011)

Bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: the potential role of daptomycin
por: Bamberger, David M
Publicado: (2007)

Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs
por: Crompton, Jason A., et al.
Publicado: (2010)

Insights Into the Evolution of Staphylococcus aureus Daptomycin Resistance From an in vitro Bioreactor Model
por: Lasek-Nesselquist, Erica, et al.
Publicado: (2019)

627. Molecular Epidemiology of Daptomycin-resistant Staphylococcus aureus Causing Bloodstream Infections
por: Gudipati, Smitha, et al.
Publicado: (2019)

The Resistance to Host Antimicrobial Peptides in Infections Caused by Daptomycin-Resistant Staphylococcus aureus
por: Bhuiyan, Md Saruar, et al.
Publicado: (2021)

Varied Contribution of Phospholipid Shedding From Membrane to Daptomycin Tolerance in Staphylococcus aureus
por: Shen, Tianwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4tlnu5jk875rq3g1e23ne369t9